Michael H Caley

Array ( [id] => 5034192 [patent_doc_number] => 20070098731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Treatment of infection due to clostridium difficile' [patent_app_type] => utility [patent_app_number] => 10/550410 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7662 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098731.pdf [firstpage_image] =>[orig_patent_app_number] => 10550410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432412 [patent_doc_number] => 20040162262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/789353 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11320 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162262.pdf [firstpage_image] =>[orig_patent_app_number] => 10789353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853091 [patent_doc_number] => 20080318834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Antimicrobial Lactoferrin Compositions for Surfaces, Cavities, and Foodstuff' [patent_app_type] => utility [patent_app_number] => 10/590591 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4837 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318834.pdf [firstpage_image] =>[orig_patent_app_number] => 10590591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693729 [patent_doc_number] => 20060153876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease' [patent_app_type] => utility [patent_app_number] => 10/545872 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23012 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153876.pdf [firstpage_image] =>[orig_patent_app_number] => 10545872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341723 [patent_doc_number] => 20040191304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Vaccine adjuvant properties of lipsomes formed at elevated temperatures from the polar chloroform extractable lipids from mycobacterium bovis bacillus calmette-guerin' [patent_app_type] => new [patent_app_number] => 10/485569 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9088 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191304.pdf [firstpage_image] =>[orig_patent_app_number] => 10485569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432374 [patent_doc_number] => 20040162258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/769626 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11536 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162258.pdf [firstpage_image] =>[orig_patent_app_number] => 10769626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263858 [patent_doc_number] => 20040241828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Automated process for detecting pathogenic organisms in water' [patent_app_type] => new [patent_app_number] => 10/484869 [patent_app_country] => US [patent_app_date] => 2004-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8351 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241828.pdf [firstpage_image] =>[orig_patent_app_number] => 10484869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648403 [patent_doc_number] => 20060134135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Bacterial virulence genes' [patent_app_type] => utility [patent_app_number] => 10/537976 [patent_app_country] => US [patent_app_date] => 2003-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14571 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134135.pdf [firstpage_image] =>[orig_patent_app_number] => 10537976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346450 [patent_doc_number] => 20040192591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Composition for treating Chlamydia infections and method for identifying same' [patent_app_type] => new [patent_app_number] => 10/722695 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12500 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192591.pdf [firstpage_image] =>[orig_patent_app_number] => 10722695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661074 [patent_doc_number] => 20060251670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Multiple variants of meningococcal protein nmb1870' [patent_app_type] => utility [patent_app_number] => 10/536215 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25121 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251670.pdf [firstpage_image] =>[orig_patent_app_number] => 10536215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549036 [patent_doc_number] => 08323917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Method of screening for compounds that inhibit the enzymatic activity of GWT1 gene product' [patent_app_type] => utility [patent_app_number] => 10/536935 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4509 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10536935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994192 [patent_doc_number] => 20070009537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Antimicrobial activity of antibodies producing reactive oxygen species' [patent_app_type] => utility [patent_app_number] => 10/534575 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34129 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009537.pdf [firstpage_image] =>[orig_patent_app_number] => 10534575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793469 [patent_doc_number] => 20060014150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Development of therapeutics for the treatment of endotoxin-meidated diseases' [patent_app_type] => utility [patent_app_number] => 10/532153 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9061 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014150.pdf [firstpage_image] =>[orig_patent_app_number] => 10532153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7311102 [patent_doc_number] => 20040143112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/690495 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11324 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143112.pdf [firstpage_image] =>[orig_patent_app_number] => 10690495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527031 [patent_doc_number] => 08043622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/682130 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11584 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043622.pdf [firstpage_image] =>[orig_patent_app_number] => 10682130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333319 [patent_doc_number] => 20040131628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Nucleic acids for the treatment of disorders associated with microorganisms' [patent_app_type] => new [patent_app_number] => 10/666733 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25860 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131628.pdf [firstpage_image] =>[orig_patent_app_number] => 10666733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84017 [patent_doc_number] => 07741437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'P. ariasi polypeptides, p. perniciosus polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 10/527500 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28888 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741437.pdf [firstpage_image] =>[orig_patent_app_number] => 10527500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693692 [patent_doc_number] => 20060153839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Production of bispecific molecules using polyethylene glycol linkers' [patent_app_type] => utility [patent_app_number] => 10/527936 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28924 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153839.pdf [firstpage_image] =>[orig_patent_app_number] => 10527936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747479 [patent_doc_number] => 20060110410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Recombinant toxin fragments' [patent_app_type] => utility [patent_app_number] => 10/527411 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23686 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110410.pdf [firstpage_image] =>[orig_patent_app_number] => 10527411 [rel_patent_id] =>[rel_patent_doc_number] =>)